The present invention relates generally to a systems and method for illuminating an interior lumen within a patient, and specifically relates to illuminated tubes that can be safely guided along a patient's lumen, such as for example a gastrointestinal tract, by monitoring light emitted from a source coupled to the tube.
Each year, in the United States, about 1.2 million nasogastric tubes are placed in patients with a significant fraction of such tubes placed in pediatric patients. One example of a nasogastric tube is a nasogastric feeding tube that can be used to administer water, nourishment and/or medicine to a patient. For example, a so-called Dobbhoff feeding tube is a small-bore flexible tube that can be inserted through a patient's nose to the stomach, and from the stomach to the first part of the small intestine (duodenum). It can be made of a radiopaque polymeric material to allow its placement using an X-ray or fluoroscope. A nasogastric tube can also be employed for other purposes. For example, a nasogastric tube can be in the form of a large bore tube that can be used for a variety of different purposes, such as decompressing the stomach for surgery and to prevent nausea/vomiting.
Although placement of nasogastric tubes in patients is relatively routine, there is a risk associated with each insertion. A misplaced nasogastric tube can lead to serious and even fatal complications. One conventional method for verification of the placement of a nasogastric tube is the measurement of the acidity of the gastric aspirate. Another method is the use of radiography to verify the location of the nasogastric tube. These conventional methods, however, suffer from a number of shortcomings. For example, the measurement of acidity can result in false affirmation of the placement of the nasogastric tube. Further, the radiation exposure associated with radiography is of great concern in pediatric patients.
Accordingly, there is a need for improved nasogastric feeding devices as well as improved methods for their insertion into a patient's gastrointestinal tract.
The present invention is directed to the ability to illuminate via light an internal or interior lumen of a patient via a fiber optic cable and an attached light source such that at least a portion of the light can be externally observed, e.g., via the naked eye or a camera. The observed light can be employed to guide a diagnostic and/or therapeutic tube (e.g., a catheter) through the lumen. The interior lumen can be any suitable lumen such as a nasogastric passage, a cardiac passage and the like.
According to one practice, the present invention is directed to an illumination system for illuminating a lumen within a body of a patient, comprising a tube having a proximal end and an opposed distal end and an internal chamber, where the tube is configured for placement within a lumen of the body, and an illumination subsystem including an optical fiber that is sized and configured to seat within the internal chamber of the tube and a light source for generating light that is emitted by the fiber optic cable. The optical fiber, when mounted within the tube and when the light source generates light, emits light at the distal end of the tube so as to transilluminate the lumen and surrounding tissue so as to be able to locate (e.g., visually or with an external device such as a camera) the distal end of the tube within the lumen of the patient.
The tube has at least one opening formed in a wall thereof, and the optical fiber has a proximal end configured for receiving light from the light source and a distal end having at least one light-emitting segment formed therein through which light from the light source exiting the optical fiber. The optical fiber is coupled to the tube such that the at least one light-emitting segment is located substantially adjacent to the at least one opening in the wall of the tube, whereby at least a portion of the light exiting the optical fiber through the at least one opening can be detected externally for guiding placement of the tube in the lumen. The light emitting segment and the opening are disposed can be disposed in registration with each other.
According to another practice, the tube can include a plurality of openings formed in a wall thereof, where the optical fiber includes at least one light-emitting segment for emitting light received from the light source, and wherein the light-emitting segment is disposed in registration with one of the plurality of openings.
The tube can include a plurality of openings formed in a wall thereof, and the optical fiber can include a plurality of light-emitting segments for emitting light received from the light source, wherein each of the light-emitting segments is disposed in registration with one of the plurality of openings.
According to one embodiment, the illumination system can be configured such that the tube corresponds to a nasogastric device. The tube has a proximal end and a distal end and is configured for placement in an individual's gastrointestinal tract, where the tube has at least one opening in a wall thereof. The nasogastric device further includes at least one fiber optic (herein also referred to as an optical fiber) extending from a proximal end configured for receiving light from a light source to a distal end through which the light exits the fiber optic, the fiber optic having at least one light-emitting segment through which light exits the fiber optic, the fiber optic being coupled to said tube such that said at least one light-emitting segment of the fiber optic is located substantially adjacent to said at least one opening in the tube wall, whereby at least a portion of the light exiting the fiber optic through said at least one opening passes through said opening and propagates through tissue to be detected externally for guiding deployment and placement of the nasogastric feeding tube in the individual's gastrointestinal tract.
In some embodiments, the nasogastric device can be a nasogastric feeding tube, which includes a passageway for administration of nourishment and/or medicine to a patient. In other embodiments, a nasogastric device according to the present teachings can be used for other purposes. For example, the nasogastric device can include a passageway to which a negative pressure can be applied for decompressing the stomach for surgery and/or to prevent nausea/vomiting.
In some embodiments, one or more light-emitting segments of the fiber optic can be positioned in a distal region of the fiber. In some such embodiments, one or more light-emitting segments of the fiber optic can be configured so as to provide side emission of the light. In some embodiments, one or more light-emitting segment(s) of the fiber optic can be configured to emit light from the distal end of the fiber optic. In some such embodiments, the light is emitted along an axial direction of the fiber optic with the divergence of the emitted light resulting in at least a portion of the light being observed externally in such a way as to allow guiding the tube along the patient's gastrointestinal tract. Further, in some embodiments in which the light is emitted from the distal end of the fiber optic, the distal region of the fiber optic is bent so as to be in substantial register with an opening in the tube, thereby enhancing the optical coupling between the light emitted by the fiber and that opening.
In some embodiments, the tube of a nasogastric device according to the present invention can include a plurality of openings and the fiber optic can include a plurality of light-emitting segments. In some such embodiments, the fiber optic is disposed within the tube such that each of the plurality of light-emitting segments is in substantial register with one of the openings in the tube so as to emit light in a plurality of directions in order to facilitate the placement of the tube within a patient's gastrointestinal tract. In some embodiments, the plurality of openings are disposed in the tube so as to allow monitoring the tube regardless of its rotational orientation as it is being guided along a patient's gastrointestinal tract. By way of example, the plurality of openings can be distributed substantially uniformly around a cross-sectional circumference of the tube.
In some embodiments, the fiber optic can be attached, e.g., glued, to an inner surface of the tube's wall. Such placement of the fiber optic can advantageously facilitate monitoring the tube via transillumination.
The tube can be formed of a variety of different polymeric materials. In general, any suitable polymeric material can be used. Some examples of such materials include, without limitation, silicone rubber, and polyurethane.
The nasogastric device can further include a light source that is optically coupled to the optical fiber to provide light thereto. For example, the light source can be coupled to the proximal end of the optical fiber to deliver light to the fiber. A variety of light sources can be employed in the practice of the invention. Some examples of suitable light sources include, without limitation, a light-emitting diode (LED), a laser diode, and an incandescent light source, among others. While in some embodiments, the light source can emit visible radiation, in other embodiments, the light source can emit radiation in the near-infrared region of the electromagnetic spectrum. Further, while in some embodiments, the emitted light can be white light, in other embodiments, the light source can emit substantially monochromatic light, e.g., red light. In some embodiments, the light source can emit light with wavelengths in a range of about 810 nm to about 850 nm.
In some embodiments, the optical fiber is a single-mode fiber while in other embodiments, it can be a multi-mode fiber. The optical fiber can have, for example, a diameter in a range of about 0.5 mm to about 2 mm, though other diameters can also be used so long as the fiber can be inserted within the nasogastric tube.
In some embodiments, an external detector can be utilized to detect externally the light emitted by the optical fiber so as to allow guiding the fiber through the patient's gastrointestinal tract. For example, in some such embodiments, a camera can be employed to the detect the light passing through the tissue. In some such embodiments, the camera can be a visible or an infrared camera.
In a related aspect, a nasogastric device is disclosed, which includes a tube having a proximal end and a distal end and is configured for placement in an individual's gastrointestinal tract. The tube can include a tubular side wall that is configured for receiving, at its proximal end, light from a light source. The tubular side wall is substantially transparent to the received light such that the light is partially transmitted along the tubular wall and is partially transmitted to external environment via passage through an outer surface of the tubular wall to be detected externally after passage through tissue for guiding deployment and placement of the nasogastric feeding tube in the individual's gastrointestinal tract.
In some embodiments, the nasogastric device can be a nasogastric feeding tube, which includes a passageway for administration of medicine and/or nourishment to a patient. In other embodiments, a nasogastric device according to the present teachings can be used for other purposes. For example, the nasogastric device can include a passageway to which a negative pressure can be applied for decompressing the stomach for surgery and/or to prevent nausea/vomiting.
By way of example, the tubular wall can be formed of clear silicone rubber, or any other suitable material.
In some embodiments, a plurality of light sources are optically coupled to the proximal end of the tubular wall to deliver light from multiple points to the tubular wall so as to ensure that substantially the entire tubular wall is illuminated. This can allow for external monitoring of the tube regardless of its rotational orientation in the individual's gastrointestinal tract.
In a related aspect, a nasogastric feeding device is disclosed, which includes a tube having a proximal end and a distal end and configured for placement in an individual's gastrointestinal tract. A light-emitting diode (LED) is coupled to the tube such that at least a portion of the light emitted by the LED passes through the opening. At least a portion of the light passing through the opening can pass through at least a portion of the surrounding tissue to be detected externally for guiding the deployment and placement of the nasogastric tube in the individual's gastrointestinal tract. For example, the LED can be positioned in the distal region of the feeding tube in proximity (and preferably in substantial register) with the opening in the distal region of the tube to allow efficient coupling of the light emitted by the LED into the tube's opening. A plurality of conductors extending through the tube can be coupled to the LED to supply electrical power thereto. In some embodiments, the conductors can be placed within an electrically insulating sleeve.
In yet another aspect, a gastrointestinal feeding device is disclosed, which includes a feeding tube having a proximal end and a distal end. A lens is coupled to the distal end of the tube. Further, an optical fiber is positioned in the tube such that its distal end is optically coupled to the lens. A light source can be used to deliver light to a proximal end of the optical fiber. The light can be emitted by the optical fiber at its distal end to be coupled to the lens. In some embodiments, a divergent lens is employed, which can cause divergence of the light received from the optical fiber such that at least a portion of the light is transmitted through at least a portion of the surrounding tissue to be monitored externally (e.g., via visualization and/or via an external detector (such as a camera)). The lens can be formed of a variety of different materials, such as a variety of suitable polymeric materials.
In a related aspect, a nasogastric device is disclosed, which includes a tube having a proximal end and a distal end and configured for placement in an individual's gastrointestinal tract, said tube having a window in a wall thereof, and at least one fiber optic having a proximal end configured for receiving light from a light source and a distal end, where the fiber optic has at least one light-emitting segment. The fiber optic is coupled to the tube such that said at least one light-emitting segment of the fiber optic is located substantially adjacent to said at least one window in the tube wall, whereby at least a portion of the light exiting the fiber optic through said at least one opening can be detected externally for guiding deployment and placement of the nasogastric tube in the individual's gastrointestinal tract.
In some embodiments, the window is substantially transparent to the light emitted by the fiber optic. In some embodiments, the tube includes a plurality of windows through one or more of which the light emitted by the fiber optic transilluminate at least a portion of the tissue surrounding the tube. In some embodiments, the window can include a color filter. In some embodiments, the nasogastric device is configured for administering any of medicine and/or nourishment to a patient. In some embodiments, the nasogastric device is configured for applying suction to a patient's stomach.
Further understanding of various aspects of the invention can be obtained by reference to the following detailed description in conjunction with the associated drawings, which are described briefly below.
These and other features and advantages of the present invention will be more fully understood by reference to the following detailed description in conjunction with the attached drawings in which like reference numerals refer to like elements throughout the different views. The drawings illustrate principals of the invention and, although not to scale, show relative dimensions.
The present invention generally relates to systems, methods, and devices for illuminating a lumen within a human body, and can include for example a tube for positioning in a lumen within a patient, where the tube includes at least an opening and/or a window in a distal region thereof. Such a device can include an illumination system or subsystem for delivering light to the tube such that at least a portion of the delivered light exits through the opening and/or window to be detected externally (via visualization or otherwise), thereby allowing a user to guide the placement of the tube within the lumen. As used herein, the term “lumen” is intended to include any internal passage or opening within the human body, and can include nasal passages, gastric passages and chambers, intestinal tracts and openings, esophageal passages, cardiac passages, venous, capillary and aortic passages, bronchial passages, uterine tracts and openings, and the like. According to one embodiment of the present invention, the invention allows positioning a gastrointestinal tube or a cardiac tube via transillumination. In some embodiments, the illumination subsystem can include an optical fiber that is positioned within the tube to transmit light received from a remote light source to the opening (and/or window) disposed in the distal region of the tube. In other embodiments, a light source can be positioned within the tube to deliver light to the opening (and/or window). Further, in some embodiments, a lens can be coupled to the distal end of the tube to receive light from an optical fiber positioned within the tube. In some such embodiments, the lens can be a divergent lens that causes the divergence of the light incident thereon such that at least a portion of the light would exit a portion of the surrounding tissue to be detected externally. A nasogastric device according to the present teachings can be used for a variety of different purposes. For example, in some embodiments, the nasogastric device can be configured for administering medicine and/or nourishment to a patient. In other embodiments, a nasogastric device according to the present teachings can be used for decompressing the stomach for surgery and/or to prevent nausea/vomiting. While in some embodiments discussed below, a nasogastric device according to the present teachings is configured as a nasogastric feeding device for administering nourishment and/or medicine to a patient, it should be understood that the teachings of the present invention are equally applicable to other types of nasogastric devices, e.g., those that are configured for decompressing a patient's stomach.
Various terms are used herein according to the ordinary meanings, unless indicated otherwise. The terms “light” and “radiation” are used herein interchangeably to refer not only to visible radiation but also to radiation in other regions of the electromagnetic spectrum, such as near-infrared. Further, the terms “fiber optic” and “optical fiber” are used herein interchangeably to refer to a waveguide through which electromagnetic radiation can be transmitted. The term “visible light” as used herein refers to radiation wavelengths in a range of about 400 nm to about 700 nm, the term “near-infrared radiation” refers to radiation having wavelengths in a range of about 750 nm to about 2500 nm. The term “transillumination” as used herein refers to the passage of light through a body portion, e.g., to allow guiding a tube through a body lumen.
More specifically, the nasogastric system 10 includes an optical fiber 20 that can be attached to an inner wall 12c of the tube 12 and can extend from the proximal end 12a of the tube 12 to the distal end 12b. In some embodiments, the optical fiber 20 can be attached to the inner wall 12c of the tube in a variety of different ways. By way of example, as shown schematically in
In other embodiments, the optical fiber 20 can be disposed in the tube 12 such that the optical fiber 20 can be inserted or extracted after the tube 12 is placed in the patient's gastrointestinal tract, e.g., after the distal region 12b of the tube 12 is placed within the patient's stomach and/or duodenum. For example, the optical fiber 20 can be inserted in the tube 12 without gluing or otherwise affixing the optical fiber to the tube. The illustrated optical fiber 20 has a proximal end 20a and a distal end 20b. The proximal end 20a of the optical fiber 20 is optically coupled to a light source 22. The light source 22 can have any selected size, shape or configuration, and can employ any suitable type of radiation or light element for producing the light and can be coupled to any suitable type of power source. According to one embodiment, the light source 22 can be configured as a handheld battery-operated light source that is capable of generating light. A variety of light sources emitting light in the visible and/or infrared region of the electromagnetic spectrum can be employed. In this embodiment, the handheld light source 22 includes a light emitting diode (LED). In some embodiments, white light with wavelengths in a range of 400 to 700 nm with a minimum of about 5000 CCT (Correlated Color Temperature) to about 6200 CCT can be used. Alternatively, monochromatic light (e.g., red light) or non-visible light (e.g., with wavelengths greater than 700 nm), i.e., near-infrared (700 nm-1400 nm) can be employed. In other embodiments, an LED emitting radiation in the infrared portion of the electromagnetic spectrum, e.g., in a wavelength range of about 600 nm to 2500 nm, can be employed. An example of such an LED is marketed by CREE under the trade designation Photo Red LED (XQEEPR). Further, the optical fiber can be composed of any suitable material, such as plastic.
With reference to
The lens 31 includes a proximal portion 40 and a distal portion 42. The proximal portion 40 of the lens includes a recess 33 through which light from the LED 24 can enter the lens. The proximal portion 40 includes a lateral surface 40a that is configured to reflect light incident thereon via total internal reflection toward the distal portion. Some of the light entering the lens via the recess 33 passes through the proximal portion of the lens without undergoing reflections at the lateral surface 40a thereof to reach the distal portion of the lens. The light passes through the distal portion of the lens and exits an output surface 44 of the lens. In this embodiment, an optical window 50 is disposed over the output surface 44 of the lens. The optical window 50 can protect the output surface of the lens and, in some embodiments, the optical window 50 can adjust one or more characteristics of the light exiting the lens. By way of example, the optical window 50 can be selected to function as a filter, e.g., a bandpass filter, to allow passage of certain wavelengths of light exiting the lens while blocking other wavelengths.
In some embodiments, the lens 31 can be configured to focus the light received from the LED 24 onto an external focal point in proximity of the input surface of the optical fiber 20 such that the divergence angle of the light propagating from the focal point to the input of the optical fiber substantially matches the numerical aperture of the optical fiber so as to allow efficient coupling of the light into the optical fiber.
In other embodiments, the optical fiber 20 can be optically coupled to the light source 22 using other mechanisms. For example, with reference to
With reference to
The light emitted via the optical fiber 20 that passes through surrounding tissue can be externally detected and monitored, visually or via an appropriate detector. For example, as shown schematically in
A variety of different fibers emitting light in a variety of different ways can be used in the practice of the invention. For example,
Referring again to
In other embodiments, the optical fiber 20 can be configured to emit radiation axially at the distal end 20b, or the optical fiber 20 can include multiple light-emitting segments 20c each of which is placed in substantial registration with one of a plurality of openings 30 in the tube 12 so as to emit light along a plurality of different directions for external detection.
As noted above, in some embodiments, subsequent to the placement of the nasogastric tube 12 within a patient's gastrointestinal tract, the optical fiber 20 used for guiding the tube 12 into position can be safely and easily removed and the tube 12 can be used for its intended purpose, e.g., to administer nourishment and/or medicine to the patient or the compress the stomach, or any other purpose.
By way of example,
By way of further illustration,
At least a portion of the light emitted by the light sources 196 is transmitted along the annulus of the tube and at least a portion of the light exits the annulus at it propagates from the proximal end of the tube to its distal end. Further, a portion of the light exits the annulus at the distal end thereof. At least a portion of the light exiting the annulus can penetrate through the surrounding tissue to be monitored externally (e.g., via visualization or otherwise), e.g., in a manner discussed above.
As noted above, a variety of light sources can be employed in nasogastric devices according to the teachings of the present invention. By way of example, in some cases, the light source can be a strobe light source (e.g., a strobe LED) that can provide repetitive flashes of radiation. Such flashes of radiation can be effective in capturing the attention of an operator of the device.
A nasogastric device according to the present teachings provides a number of advantages. In particular, it allows safe placement of a nasogastric tube in a patient's gastrointestinal tract without the need to expose the patient to potentially harmful radiation. This can be particularly advantageous for pediatric patients. Further, a nasogastric feeding device according to the present teachings is easy to use.
The illumination system of the present invention can be used to illuminate or transilluminate other types of lumens and areas within the patient. For example, the above embodiments are directed to illuminating nasal and gastric passages or lumens within the body. Likewise, the illumination system of the present invention can be used to illuminate lumens in other regions of the body, including cardiac passages or lumens, including for example, venous, aortic, and capillary lumens or passages. For example, the illumination system of the present invention can also be used to locate or visually show the location of a device inserted within a lumen in the heart region of the patient.
Once the tube 12 is properly positioned within the lumen 208 of the body, the optical fiber 20 can be removed from the chamber 12d of the tube 12. A further medical device can then be inserted into the tube so as to perform a specific function or action at the surgical site. For example, the tube and illumination system can be employed during a cardiac catheterization procedure so as to assess heart function and diagnosis cardiac conditions. During this procedure, the tube or catheter 12 is inserted into a vein in the arm, neck or groin of the patient, and then the tube, with the assistance of the illumination system can be passed through the body to a selected site or location in the heart. The illumination system can be used to generate and emit light in the red light range so as to assist the doctor in determining the location of the catheter in the human body.
According to another practice, the tube 12 and the illumination system can be used as part of an angiography or arteriography procedure. During the angiography procedure, the tube or catheter 12 can be inserted into a lumen, such as vein or artery (e.g., femoral artery) of the patient, and the illumination system (e.g., light source 22 and optical fiber 20) helps emit light within the artery to transilluminate the artery and surrounding tissue. The light can help the doctor locate or thread the tube to the proper location within the heart. Once the tube is properly located, the optical fiber can be removed from the tube. The angiography procedure can be used to help visualize the inside, or lumen, of blood vessels and organs of the body, with particular interest in the arteries, veins, and the heart chambers. This is traditionally done by injecting a radio-opaque contrast agent into the blood vessel and imaging using X-ray based techniques such as fluoroscopy.
According to still another practice, the illumination system can be used to assist in angioplasty procedures. For example, the tube or catheter 12 can be inserted within a vein and the optical fiber 20 can be inserted within the tube. The illumination system via the optical fiber 20 emits light at the distal end of the tube to help locate the tube within the body. Once the tube is properly positioned, the optical fiber can be removed from the tube. Angioplasty is a minimally invasive, endovascular procedure to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis. A deflated balloon attached to a catheter (e.g., a balloon catheter) is passed over a guide-wire into the narrowed vessel and then inflated to a fixed size. The balloon forces expansion of the blood vessel and the surrounding muscular wall, allowing an improved blood flow. A structural support, such as a stent, can then be inserted at the time of ballooning to ensure the vessel remains open, and the balloon is then deflated and withdrawn.
By way of further illustration,
Those having ordinary skill in the art will appreciate that various changes can be made to the above embodiments without departing from the scope of the invention.
This patent application claims priority to U.S. provisional patent application Ser. No. 62/787,688, filed on Jan. 2, 2019, and entitled Positioning Nasogastric Tube Via Transillumination, the contents of which are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2908197 | Wells et al. | Oct 1959 | A |
3285242 | Wallace | Nov 1966 | A |
3592199 | Ostensen | Jul 1971 | A |
4414608 | Furihata | Nov 1983 | A |
4726074 | Baclit et al. | Feb 1988 | A |
D331634 | Browne | Dec 1992 | S |
5353208 | Moore | Oct 1994 | A |
5609561 | Uehara et al. | Mar 1997 | A |
5682199 | Lankford | Oct 1997 | A |
5702349 | Morizumi | Dec 1997 | A |
5743848 | Koeda et al. | Apr 1998 | A |
5765223 | McCausland | Jun 1998 | A |
6007485 | Koeda et al. | Dec 1999 | A |
6099147 | Ziegenfuss | Aug 2000 | A |
6135947 | Watanabe et al. | Oct 2000 | A |
6257741 | Williams et al. | Jul 2001 | B1 |
6540389 | Novak et al. | Apr 2003 | B1 |
6819505 | Cassarly et al. | Nov 2004 | B1 |
6937791 | Guy | Aug 2005 | B2 |
6991603 | Krupa et al. | Jan 2006 | B2 |
7115091 | Root et al. | Oct 2006 | B2 |
D533939 | Root et al. | Dec 2006 | S |
7193519 | Root et al. | Mar 2007 | B2 |
7198397 | Bennett et al. | Apr 2007 | B2 |
7229201 | Krupa et al. | Jun 2007 | B2 |
D551762 | Root et al. | Sep 2007 | S |
D561336 | Laflash et al. | Feb 2008 | S |
D581052 | Root et al. | Nov 2008 | S |
D623786 | Wessel | Sep 2010 | S |
7798692 | Krupa et al. | Sep 2010 | B2 |
D629537 | Hsu et al. | Dec 2010 | S |
D631567 | Lodhie | Jan 2011 | S |
8033704 | Krupa et al. | Oct 2011 | B2 |
8152715 | Root et al. | Apr 2012 | B2 |
D662231 | Sakamoto et al. | Jun 2012 | S |
D663445 | Sakamoto et al. | Jul 2012 | S |
D663464 | Lee | Jul 2012 | S |
D666340 | Sakamoto et al. | Aug 2012 | S |
D669200 | Chen et al. | Oct 2012 | S |
D671241 | Sakamoto et al. | Nov 2012 | S |
D671242 | Sakamoto et al. | Nov 2012 | S |
D671243 | Sakamoto et al. | Nov 2012 | S |
D675349 | Parker et al. | Jan 2013 | S |
D685506 | Pickard et al. | Jul 2013 | S |
D690383 | Sheikh et al. | Sep 2013 | S |
8534890 | Goto et al. | Sep 2013 | B2 |
8801253 | Krupa et al. | Aug 2014 | B2 |
D715463 | Jun | Oct 2014 | S |
9022628 | Krupa et al. | May 2015 | B2 |
9055863 | Krupa et al. | Jun 2015 | B2 |
D739586 | Hong | Sep 2015 | S |
D744674 | Wu et al. | Dec 2015 | S |
D753322 | Taylor | Apr 2016 | S |
D760928 | Bao | Jul 2016 | S |
D768321 | Inskeep | Oct 2016 | S |
D775752 | Nook et al. | Jan 2017 | S |
D778473 | Cooper | Feb 2017 | S |
D793595 | Lesperance et al. | Aug 2017 | S |
D804064 | Taylor et al. | Nov 2017 | S |
D810325 | Guo | Feb 2018 | S |
D813424 | Shum et al. | Mar 2018 | S |
D836227 | Root | Dec 2018 | S |
10281709 | Root et al. | May 2019 | B2 |
10768407 | Root et al. | Sep 2020 | B2 |
10782518 | Root et al. | Sep 2020 | B2 |
11016282 | Root et al. | May 2021 | B2 |
20030009084 | May et al. | Jan 2003 | A1 |
20030074708 | Hogg | Apr 2003 | A1 |
20030091820 | Robbins | May 2003 | A1 |
20030158503 | Matsumoto | Aug 2003 | A1 |
20040213001 | Sayers et al. | Oct 2004 | A1 |
20040218858 | Guy | Nov 2004 | A1 |
20040246744 | Krupa et al. | Dec 2004 | A1 |
20050162848 | Dalton et al. | Jul 2005 | A1 |
20050201100 | Cassarly et al. | Sep 2005 | A1 |
20060183977 | Ishigami et al. | Aug 2006 | A1 |
20070104664 | Maltezos et al. | May 2007 | A1 |
20070173695 | Hirata | Jul 2007 | A1 |
20070253188 | Klipstein et al. | Nov 2007 | A1 |
20080027408 | Wilson et al. | Jan 2008 | A1 |
20080039715 | Wilson | Feb 2008 | A1 |
20080091064 | Laser | Apr 2008 | A1 |
20080174996 | Lu et al. | Jul 2008 | A1 |
20080194973 | Imam | Aug 2008 | A1 |
20090040783 | Krupa et al. | Feb 2009 | A1 |
20090185392 | Krupa | Jul 2009 | A1 |
20090287197 | Hanley et al. | Nov 2009 | A1 |
20100226127 | Bigliatti et al. | Sep 2010 | A1 |
20100277894 | Kim | Nov 2010 | A1 |
20110194295 | Householder et al. | Aug 2011 | A1 |
20120184924 | Ejike et al. | Jul 2012 | A1 |
20130046172 | Waitzman | Feb 2013 | A1 |
20140148653 | McMahon et al. | May 2014 | A1 |
20140275986 | Vertikov | Sep 2014 | A1 |
20150219313 | Marcaly | Aug 2015 | A1 |
20160050990 | Hayes | Feb 2016 | A1 |
20170122525 | Root et al. | May 2017 | A1 |
20170123131 | Root et al. | May 2017 | A1 |
20170123199 | Jones et al. | May 2017 | A1 |
20170197002 | Dobrinsky et al. | Jul 2017 | A1 |
20170274184 | Isaacson | Sep 2017 | A1 |
20190361217 | Root et al. | Nov 2019 | A1 |
20200081241 | Root et al. | Mar 2020 | A1 |
20200205640 | Miike et al. | Jul 2020 | A1 |
20210278657 | Root et al. | Sep 2021 | A1 |
20210299298 | Root et al. | Sep 2021 | A1 |
20210307421 | Root et al. | Oct 2021 | A1 |
Number | Date | Country |
---|---|---|
201680208 | Dec 2010 | CN |
205079073 | Mar 2016 | CN |
2846179 | Mar 2015 | EP |
S56-59005 | May 1981 | JP |
H04288960 | Oct 1992 | JP |
H0751282 | Feb 1995 | JP |
H8-10220 | Jan 1996 | JP |
2000171725 | Jun 2000 | JP |
200240299 | Jul 2000 | JP |
3148028 | Mar 2001 | JP |
2002345748 | Dec 2002 | JP |
2004536639 | Dec 2004 | JP |
200759073 | Aug 2005 | JP |
200791119 | Apr 2007 | JP |
2008539479 | Nov 2008 | JP |
2010528818 | Aug 2010 | JP |
201325924 | Jul 2011 | JP |
2013123477 | Jun 2013 | JP |
2013533049 | Aug 2013 | JP |
2013198644 | Oct 2013 | JP |
2009056290 | May 2014 | JP |
2015056137 | Mar 2015 | JP |
2015077336 | Apr 2015 | JP |
2016087091 | May 2016 | JP |
20190067110 | Jun 2019 | KR |
2008016895 | Feb 2008 | WO |
2008017718 | Feb 2008 | WO |
2010091097 | Aug 2010 | WO |
2015038971 | Mar 2015 | WO |
2018207753 | Nov 2018 | WO |
Entry |
---|
Japanese Office Action, JP2018-542993, dated May 12, 2021, 15 pages. |
European Extended Search Report, 21164168.3, dated Apr. 23, 2021, 7 pages. |
European Examination Report, 16798028.3, dated Jul. 1, 2021, 4 pages. |
International Preliminary Report on Patentability, PCT/US2019/069111, dated Jun. 16, 2021, 6 pages. |
International Search Report and Written Opinion, PCT/US2021/025050, dated Jul. 6, 2021, 13 pages. |
European Examination Report, 16794169.9, dated Nov. 17, 2021, 10 pages. |
International Invitation to Pay Additional fees and Partial Search Report, PCT/US2021/022948, dated Jun. 29, 2021, 13 pages. |
International Preliminary Report on Patentability, PCT/US2019/069111, dated Jul. 15, 2021, 7 pages. |
International Search Report and Written Opinion, PCT/US2021/022948, dated Aug. 19, 2021, 21 pages. |
Japanese Office Action, JP2018-542988, dated Sep. 1, 2021, 4 pages. |
Japanese Office Action, JP2018-542988, dated Oct. 21, 2020, 10 pages. |
Japanese Office Action, JP2018-542993, dated Oct. 14, 2020, 14 pages. |
Merriam-Webster, https://www.merriam-webster.com/dictionary/periphery, Oct. 20, 2020, 8 pages. |
Oxford English Dictionary, https://www.oed.com/view/Entry/141021#eid30851400, Oct. 20, 2020, 2 pages. |
United States Examiner's Answer to Appeal Brief, U.S. Appl. No. 15/337,922, dated Oct. 23, 2020, 10 pages. |
European Search Report, 16794163.2, dated Jan. 7, 2020, 7 pages. |
International Preliminary Report on Patentability for corresponding PCT Application No. PCT/US2016/059361, dated May 11, 2018, 10 pages. |
International Search Report and Written Opinion, PCT/US2019/069111, dated Mar. 25, 2020, 24 pages. |
International Search Report/Written Opinion for corresponding PCT Application No. PCT/US2016/059361, dated Apr. 4, 2017, 16 pages. |
International Search Report/Written Opinion for corresponding PCT Application No. PCT/US2016/059406, dated Apr. 7, 2017, 9 pages. |
International Search Report/Written Opinion for corresponding PCT/US2016/059451, dated Jun. 19, 2017; 15 pages. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, for PCT/US2016/059451, dated Mar. 16, 2017; 6 pages. |
Invitation to Pay Additional Fees for corresponding PCT Application No. PCT/US2016/059361, dated Feb. 3, 2017, 6 pages. |
Office Action (Notice of Reasons for Refusal) dated Oct. 3, 2023 for Japanese Patent Application No. 2021-538760. |
Canadian Office Action for Canadian Patent Application No. 3,125,671 dated Dec. 20, 2023. |
European Office Action (Communication Pursuant to Article 94(3) EPC) for European Patent Application No. 19845684.0 dated Dec. 20, 2023. |
Number | Date | Country | |
---|---|---|---|
20200205640 A1 | Jul 2020 | US |
Number | Date | Country | |
---|---|---|---|
62787688 | Jan 2019 | US |